Inorganic Nitrite Delivery to Improve Exercise Capacity in HFpEF

Trial Profile

Inorganic Nitrite Delivery to Improve Exercise Capacity in HFpEF

Recruiting
Phase of Trial: Phase II

Latest Information Update: 27 Apr 2017

At a glance

  • Drugs Sodium nitrite (Primary)
  • Indications Heart failure
  • Focus Proof of concept; Therapeutic Use
  • Acronyms INDIE-HFpEF
  • Most Recent Events

    • 10 Jun 2017 Biomarkers information updated
    • 27 Apr 2017 According to a Savara Pharmaceuticals media release, the company expects to announce results from this study, in the first half of 2018.
    • 07 Jan 2017 According to a Mast Therapeutics media release, results from this trial are expected in the first quarter of 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top